Found 16 matching trials
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
PHASE3The primary efficacy index of this study is to compare the OS of the two gr...
Location
First Affiliated Hospital Bengbu Medical College
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
NAThis project is a prospective, multi-center, multi-cohort exploratory clini...
Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma
PHASE2The investigators design a phase II clinical study to explore the efficacy ...
Location
Multiple Locations
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors
PHASE1to assess the safety, tolerability,PK and efficacy profile of two doses (60...
Location
Cancer institute & hospital, chinese academy of medical sciences
The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer
PHASE4To evaluate the efficacy and safety of the combination regimen of Icaritin ...
Location
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Single-Arm Clinical Study of Icaritin Soft Capsules as Adjuvant Therapy for Hepatocellular Carcinoma Patients at High Risk of Postoperative Recurrence
PHASE2Observing the Efficacy and Safety of Icaritin Soft Capsules as Postoperativ...
Status
Active Not Recruiting
Location
the Second Affiliated Hospital, Zhejiang University School of Medicine
Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients
PHASE2Icaritin is a drug that has been approved by the National Medical Products ...
Location
Multiple Locations
The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects
PHASE3The enriched HBV-related advanced HCC patient population (composite biomark...
Location
Anhui Provincial Hospital
Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors
PHASE2This is a single-center, single-arm, prospective trial to explore the effic...
Location
Clinical Medical College of Yangzhou University
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
PHASE2Icaritin is a drug that has been approved by the National Medical Products ...
Location
Sun Yat-sen Memorial Hospital